The rise in Senores Pharmaceuticals share came after the company's strong show in the December quarter (Q3FY25) results ...
Senores Pharmaceuticals IPO: The initial public offering (IPO) of pharma company Senores Pharmaceuticals Ltd is set to hit Dalal Street on Friday, December 20. The company plans to raise a little ...
Senores Pharmaceuticals IPO GMP, Senores Pharmaceuticals IPO Allotment Status, Senores Pharmaceuticals IPO Allotment Status Check Online: The allotment status of the initial public offer (IPO ...
In Regulated Markets, robust growth in the CDMO and CMO segment was partly offset by a softer performance in the Marketed ...
6 min read. Updated: 20 Dec 2024, 05:10 PM IST Senores Pharmaceuticals is a manufacturer of a range of pharmaceutical products primarily for the regulated markets of the US, Canada, and the UK ...
Senores Pharmaceuticals IPO Day 3 Live Updates: Senores Pharmaceuticals' initial public offering achieved a subscription rate of 13.93 times on Monday, which marked the second day of bidding.
Senores Pharmaceuticals Share Price, IPO Listing Live: The company raised Rs 260.63 crore from anchor investors. (Image: Freepik) Senores Pharmaceuticals Share Price, IPO Listing Highlights ...
Senores Pharmaceuticals Ltd share price was up by 3.41% from the previous closing price of ₹542.15. Who are peers of Senores Pharmaceuticals Ltd? The peers of Senores Pharmaceuticals Ltd are Sun ...
Senores Pharmaceuticals jumped 14.09% to Rs 568.05 after the pharma company's consolidated net profit surged 131.08% to Rs 16.43 crore on 30.90% rise in revenue from operations to Rs 103.02 crore in ...
Senores Pharmaceuticals stock debuts on the NSE at ₹600.00, registering a robust 53.5 per cent premium against the IPO price of ₹391. The stock touched an intraday high of ₹609.65 ...
Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.